A Change in Tides: New Coverage on MeadWestvaco, Mesabi Trust, Minerals Technologies, Molycorp and Monsanto

NEW YORK, December 29, 2014 /PRNewswire/ --

Moments ago, Analysts Review released new research updates concerning several important developing situations including MeadWestvaco (NYSE: MWV), Mesabi Trust (NYSE: MSB), Minerals Technologies (NYSE: MTX), Molycorp (NYSE: MCP), and Monsanto (NYSE: MON). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.

To access our full PDF reports on a complementary basis, please visit the links below.

--

Today's update concerns the following companies:

============

Full PDF Download Links (you may have to copy and paste the following links into your browser):

MWV Research Report: ( http://get.analystsreview.com/pdf/?c=MeadWestvaco&d=29-Dec-2014&s=MWV ),

MSB Research Report: ( http://get.analystsreview.com/pdf/?c=Mesabi%20Trust&d=29-Dec-2014&s=MSB ),

MTX Research Report: ( http://get.analystsreview.com/pdf/?c=Minerals%20Technologies&d=29-Dec-2014&s=MTX ),

MCP Research Report: ( http://get.analystsreview.com/pdf/?c=Molycorp&d=29-Dec-2014&s=MCP ),

MON Research Report: ( http://get.analystsreview.com/pdf/?c=Monsanto&d=29-Dec-2014&s=MON ).

============

--

Analyst Update: Technology Supply Approval, Financial Results, Agreements,and Upcoming Earnings

Reviewed by: Rohit Tuli, CFA®  

The U.S. stock market prolonged its winning streak on Friday, ending the day in green, as positive sentiments continued to buoy the markets after the Christmas holiday. The Dow Jones Industrial Average (DJIA) gained for seven consecutive trading days and ended the session at 18,053.71, up 0.13%, while the S&P 500 moved up 0.33% to 2088.77. The Nasdaq Composite advanced 0.70% and closed at 4,806.86, its highest level since March 2000. The European markets will remain close till Monday. The Asian stocks were mostly higher, as investors played down a slew of Japanese economic reports on inflation, industrial output and the labor market.  The data showed that inflation in Japan was slowing, despite efforts of increasing it; however, the market reaction to the November figures was largely muted.

MeadWestvaco Corp. (MeadWestvaco) has received a grant to provide its Medication Event Monitoring System (MEMS™) to The Bill & Melinda Gates Foundation. The system is being used in the foundation's new demonstration projects on pre-exposure prophylaxis (PrEP) medications to help prevent the spread of HIV/AIDS in sub-Saharan Africa and India.

Mesabi Trust (Mesabi Trust) reported robust increase in third quarter fiscal 2015 top line; with solid improvements registered in bottom line as well. During the quarter, the Company's pellets produced increased 19.3% YoY to 1.2 million tons, while pellets shipped surged 77.8% YoY to 1.9 million tons.

Minerals Technologies Inc. (Minerals Technologies) signed a commercial agreement with a North American paper company to provide FulFill® E-325 High Filler Technology. The Company has till date signed 18 agreements with paper mills to provide FulFill® E-325 technology that was introduced in late 2010.

Molycorp Inc. (Molycorp) posted third quarter 2014 results with revenues at $123.9 million, down 16.9% YoY. The fall in topline was attributed to its Chemical & Oxides segment and Magnetic Materials and Alloys - its major revenue contributors. The Company's trimmed its operating loss to $49.4 million, from $59.0 million in Q3 2013.

Monsanto Company (Monsanto) plans to report its first quarter fiscal 2015 financial results and annual research and development pipeline update on January 7, 2015, prior to market open. The Company will also hold a conference call to discuss the results. The Company through a press release issued on December 22, 2014, informed that the conference call is scheduled on January 7, 2014 at 8:30 a.m. CT or 9:30 a.m. ET.

--

About Analysts Review  

At Analysts Review, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Analysts Review comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.

Analysts Review was designed for investors. By providing the best information available, we have set ourselves apart as one of the premier online investor communities.

--

Editor Note: This is not company news. We are an independent source and our views do not reflect the companies mentioned.

Compliance Procedure: Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA®. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

Further Resources: For more information about this release including editorial notes, compliance procedures and legal disclosures, please visit: http://www.analystsreview.com/editors

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED